With pandemic pain slowly residing and lab companies awash in COVID-19 testing revenues, it’s not surprising that the M&A cauldron is heating up. While volume has yet to rebound to pre-pandemic … [Read more...]
M&A Report
Investors Skeptical of Qiagen-Quidel Merger but Believe GenMark Diagnostics Acquisition Rumor
March 5, 2021
DX Deals
Global Collaboration Seeks to Develop Game-Changing Handheld COVID-19 Breathalyzer Test
February 19, 2021
A handheld, easy-to-use breathalyzer device capable of accurately detecting COVID-19 at the point of care would represent a breakthrough in the effort to contain the spread of the virus. That vision … [Read more...]
M&A Report
Hologic Turns COVID-19 Testing Cash into Strategic Acquisitions in Core Women’s Health Space
February 19, 2021
M&A deal making in the diagnostics marketing is off to a very fast start in 2021. The biggest deal announced in January was PerkinElmer’s bid to expand its infectious disease testing capabilities … [Read more...]
Industry Buzz
Myriad Genetics Puts Its Autoimmune Division Up for Sale
January 30, 2021
What a difference a pandemic makes! Last year at this time, molecular genetic testing was a fairly soft market. But the unprecedented and unexpected demand for COVID-19 diagnostics has lifted the … [Read more...]
DX Deals
Siemens, California Health Network and Biopharm Research Company Partner for Enhanced Liver Fibrosis Testing
January 10, 2021
Although COVID-19 remains the driving force, non-pandemic-related strategic deal making continues. Among the most impactful deals announced in December is the partnership among Renown Institute for … [Read more...]
M&A Review
2020 M&A Year in Review: Deal Making Was Low in Volume but High in Impact
January 10, 2021
Not surprisingly, the COVID-19 pandemic exerted a pronounced chilling effect on M&A activity in the diagnostic space as both buyers and sellers adopted a wait-and-see attitude. But the decline in … [Read more...]
M&A Report
CompuGroup Medical Makes Major LIS Play by Acquiring Schuyler House
January 10, 2021
It seems fitting that the pandemic year of 2020 should end not with a bang but a whimper. December was the slowest month in M&A deal making of not only this year but many years in recent memory … [Read more...]
M&A Report
Look for Health Care Mergers and Acquisitions to Resurge in 2021
December 2, 2020
Last year at this time, the expectation was that 2020 would be an unusually active year for health care mergers and acquisitions. But the pandemic forced deal makers to shelve their plans and await … [Read more...]
M&A Report
Exact Sciences Makes a Bold Double Play to Bolster Its Early Cancer Detection Capabilities
November 5, 2020
Although volume was light, October was a robust month for M&A deal making in terms of impact, especially in the cancer diagnostics space. The month started with the announcement of Invitae’s … [Read more...]
Inside the Lab Industry
Equity Fund Acquires Controlling Stake in Ancestry.com as Demand for At-Home Genetic Testing Fades
November 2, 2020
Many believe that the boom for direct to consumer genetic testing had passed even before the pandemic began. Still, the sector is abuzz with strategic activity. In August, private equity firm … [Read more...]
